
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 34.740 | 69.800 | 35.060 |
Shares | 52.710 | 52.710 | 0.000 |
Bonds | 16.620 | 16.620 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 7.079 | 10.482 |
Price to Book | 1.264 | 1.617 |
Price to Sales | 0.622 | 1.114 |
Price to Cash Flow | 2.338 | 7.141 |
Dividend Yield | 5.911 | 3.994 |
5 Years Earnings Growth | 11.335 | 12.310 |
Name | Net % | Category Average |
---|---|---|
Cash | 34.740 | 8.033 |
Corporate | 16.536 | 3.509 |
Government | 0.080 | 0.793 |
Number of long holdings: 72
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Absa Trs 040822 A_R Receive Leg F Monthly | - | 46.82 | - | - | |
15SEP22 DCAR | ZAD000441541 | 17.75 | - | - | |
15SEP22 DCAP | ZAD000435840 | 16.06 | - | - | |
Prescient Money Market Fund B3 | ZAE000140885 | 8.25 | 1.000 | 0% | |
Standard Bank Ncd 6.35 250423 | - | 7.26 | - | - | |
Standard Bank Ncd 7 090623 | - | 7.22 | - | - | |
Transnet Soc Ltd 0 Tsp261 070223 | - | 1.04 | - | - | |
Reinet Invest | LU0383812293 | 0.86 | 52,650 | -0.60% | |
Pepkor | ZAE000259479 | 0.72 | 2,739 | -0.62% | |
Mediclinic International PLC | GB00B8HX8Z88 | 0.72 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fairtree Equity Prescient A1 Fund | 32.56B | 13.03 | 15.69 | 11.95 | ||
Fairtree Equity Prescient A3 Fund | 32.56B | 12.55 | 14.74 | 11.40 | ||
Fairtree Equity Prescient B3 Fund | 32.56B | 13.68 | 17.31 | 13.96 | ||
Fairtree Equity Prescient A2 Fund | 32.56B | 11.24 | 13.67 | 12.78 | ||
Fairtree Equity Prescient B2 Fund | 32.56B | 11.47 | 11.04 | 12.36 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review